Secondary Metabolites from Marine Sources with Potential Use as Leads for Anticancer Applications

The development of novel anticancer agents is essential to finding new ways to treat this disease, one of the deadliest diseases. Some marine organisms have proved to be important producers of chemically active compounds with valuable bioactive properties, including anticancer. Thus, the ocean has proved to be a huge source of bioactive compounds, making the discovery and study of these compounds a growing area. In the last few years, several compounds of marine origin, which include algae, corals, and sea urchins, have been isolated, studied, and demonstrated to possess anticancer properties. These compounds, mainly from securamines and sterols families, have been tested for cytotoxic/antiproliferative activity in different cell lines. Bioactive compounds isolated from marine organisms in the past 5 years that have shown anticancer activity, emphasizing the ones that showed the highest cytotoxic activity, such as securamines H and I, cholest-3 beta,5 alpha,6 beta-triol, (E)-24-methylcholest-22-ene-3 beta,5 alpha,6 beta-triol, 24-methylenecholesta-3 beta,5 alpha,6 beta-triol, and 24-methylcholesta-3 beta,5 alpha,6 beta-triol, will be discussed in this review. These studies reveal the possibility of new compounds of marine origin being used as new therapeutic agents or as a source of inspiration to develop new therapeutic agents.

Automated summary

Marine organisms have been found to produce bioactive compounds with anticancer properties, particularly from securamines and sterols families. In the last few years, compounds isolated from marine sources have been studied for their cytotoxic/antiproliferative activity in different cell lines, showing promising results. These findings suggest the potential for new therapeutic agents derived from marine sources in the treatment of cancer.